Kymera Therapeutics

Kymera Therapeutics Honored by Boston Business Journal as a 2021 Best Places to Work Company

WATERTOWN, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Boston Business Journal (BBJ) has